Ignite Creation Date:
2024-05-05 @ 11:27 AM
Last Modification Date:
2024-10-26 @ 9:07 AM
Study NCT ID:
NCT00046150
Status:
COMPLETED
Last Update Posted:
2008-06-19
First Post:
2002-09-20
Brief Title:
12 WeekComparing Safety of HMR1964 Insulin Aspart Used in Continuous Subcutaneous Infusion in Type 1 Diabetes
Sponsor:
Sanofi
Organization:
Sanofi
Study Overview
Official Title:
12-Week Multinational Multicenter Controlled Open 11 Randomized Parallel Clinical Trial Comparing the Safety of HMR1964 and Insulin Aspart Used in Continuous Subcutaneous Insulin Infusion CSII in Subjects With Type 1 Diabetes Mellitus
Status:
COMPLETED
Status Verified Date:
2008-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to compare the safety of HMR 1964 and insulin aspart when used in external pumps with respect to catheter occlusions GHb assessment insulin doses blood glucose parameters hypoglycemic episodes unexplained hyperglycemia adverse events laboratory data and vital signs
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| HMR1964 | None | None | None |